Maartje van den Biggelaar/sanquin.nl
Aug 2, 2026, 08:27
Maartje van den Biggelaar: HemoTwin Opens Doors for Aspiring Researchers
Maartje van den Biggelaar, Head of Laboratory of Proteomics at Sanquin, Lecturer of Pharmaceutical Biotechnology at Utrecht University, shared a post on LinkedIn:
“Within the national phramework of HemoTwin, we are looking for 3 PhD students to advance precision hemostasis in congenital bleeding disorders and bleeding disorders of unknown cause using mass spectrometry-based proteomics.
Join our team!”
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 04:43Tom Tang: Preventing Post Thrombotic Syndrome Starts With Early DVT Prevention
-
Sep 17, 2026, 04:35Veronica Sanchez: Menopause as a Risk for Heart Disaese
-
Sep 17, 2026, 03:20Jessica Frye: Understanding VTE in Pregnancy and the Postpartum Period
-
Sep 17, 2026, 03:04Leonardo Roever: Exploring the Role of Glutamine Metabolism in Atherosclerosis
-
Sep 17, 2026, 02:36Wolfgang Miesbach: Effectiveness of Avatrombopag in ITP Treatment
-
Sep 17, 2026, 02:34Aleksandar Sič: The Endothelium and Cardiovascular Toxicity in Blood Cancers
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?